Heparin-binding Protein and Lungedema in ICU Patients.
Recruiting
Observational Study
Lung Edema
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 25 (estimated)
- Sponsor
- Umeå University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this single center observational cohort study is to investigate the relationship between physiological measures of lung oedema, and the biomarker Heparin-binding Protein (HBP).
The main questions it aims to answer are:
* Does the concentration of HBP in plasma correlate with measures of lung vascular permeability and extravascular water in the lungs?
* Does the concentration of HBP i…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients \>18 years
* Monitored with a PiCCO system
Exclusion Criteria:
• Patients transferred from another ICU
Contacts